TSS
MDCX

Two Sigma Securities’s Medicus Pharma MDCX Stock Holding History

Two Sigma Securities’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,617
Closed -$7.17K – 2515
2026
Q1 		$7.17K Buy
+15,617
New +$16.3K ﹤0.01% 1493

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Two Sigma Securities's MDCX Position: Q2 2026 in Review

Two Sigma Securities sold out of Medicus Pharma (MDCX) in Q2 2026, closing a stake of 15,617 shares — an estimated $7.17K sold.

Two Sigma Securities first reported a position in MDCX in Q1 2026 and held it in 1 quarter. The position peaked at $7.17K in Q1 2026. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Two Sigma Securities reported no remaining Medicus Pharma position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 15,617 Medicus Pharma shares in Q2 2026, an estimated $7.17K.
  • Two Sigma Securities first reported a position in Medicus Pharma in Q1 2026 and held it in 1 quarter.
  • Two Sigma Securities's Medicus Pharma position peaked at $7.17K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.